Status:
TERMINATED
Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Hypercholesterolemia, Familial
Lipid Metabolism, Inborn Errors
Eligibility:
All Genders
8+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to provide an investigational drug to patients with a specific type of hypercholesterolemia (high cholesterol) or sitosterolemia (unusually high absorption of non-choleste...
Eligibility Criteria
Inclusion
- Homozygous familial hypercholesterolemia or sitosterolemia
Exclusion
- Patient has a condition which, in the opinion of the investigator, might pose a risk to the patient, interfere with participation in the study, or does not meet the additional criteria as required by the study
Key Trial Info
Start Date :
July 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2005
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT00092833
Start Date
July 1 2002
End Date
May 1 2005
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.